Highlights and Quick Summary
- Net Current Asset Value for the quarter ending June 30, 2023 was $169 Million (a -16.73% decrease compared to previous quarter)
- Year-over-year quarterly Net Current Asset Value decreased by -19.04%
- Annual Net Current Asset Value for 2022 was $212 Million (a -34.87% decrease from previous year)
- Annual Net Current Asset Value for 2021 was $325 Million (a -3.9% decrease from previous year)
- Annual Net Current Asset Value for 2020 was $338 Million (a 2635.82% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Current Asset Value of Dyne Therapeutics, Inc.
Most recent Net Current Asset Valueof DYN including historical data for past 10 years.Interactive Chart of Net Current Asset Value of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Net Current Asset Value for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $168.63 | $202.51 | – | – | – |
| 2022 | $211.63 | $208.3 | $244.97 | $293.15 | $211.63 |
| 2021 | $324.93 | $371.89 | $446.75 | $473.62 | $324.93 |
| 2020 | $338.12 | $365.21 | $0.0 | $0.0 | $338.12 |
| 2019 | – | – | $12.36 | $0.0 | $12.36 |
| 2018 | – | – | – | – | $4.07 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology